Check out today's blog post with updates about ASCO from our Science and Research Team
Here is the link: go2foundation.org/blog/what...
What You Need to Know: ASCO 2020 - Lung Cancer Support
What You Need to Know: ASCO 2020
Miranda_GO2Partner
Written by
Miranda_GO2
Partner
To view profiles and participate in discussions please or .
1 Reply
•
DenzieModeratorVolunteer
“The results showed that taking Tagrisso (osimertinib) as an additional therapy (known as an “adjuvant” therapy) after surgery and sometimes chemotherapy made a significant difference in the percentage of patients who had a recurrence. After 2 years, 89% of patients on Tagrisso were lung cancer-free vs. 53% of those not taking it.”
Sending hope that this game changer gets approved soon!
Not what you're looking for?
You may also like...
Tagrisso prolongs progression free survival in resectable EGFR patients.
Okay, I’m science fan geeking out this week. The American Society of Clinical Oncology (ASCO) is...
Opdivo..What do You Know
Help. Doctor has changed mind again. He is now checking my insurance to see if it will approve me...
Just need advice what to expect
Ok so I'm new to tho page my mum is 55 she had copd to start with now she has small cell lung...
Found out have brain tumor - What do You Know
Hi
Whatever you can say to help me is appreciated. My lung cancer is in maintenance mode as I have...
I don't know what has happened
My friend has terminal lung cancer and he was originally admitted to hospital because of the way he...
How do you know where is the best cancer center to treat you?
Our dear Serrecko is gone
New Member: Living with Stage 4 Lung Cancer and Advocating for Awareness and Research
